“Comment on ‘Apixaban Vs. Aspirin for Stroke Prevention in People With Subclinical Atrial Fibrillation and a History of Stroke or Transient Ischemic Attack: Subgroup Analysis of the ARTESiA Randomized Controlled Trial’”. Bleeding, Thrombosis and Vascular Biology 4, no. 2 (April 16, 2025). Accessed June 6, 2025. https://www.btvb.org/btvb/article/view/179.